Haemonetics HAE
NYSE HAE
$101.14 -2.02 (-1.96%)
As of: Sep 10, 2026 · 3:59 PM EDT

Haemonetics (HAE) EBT Margin Growth (1y) (2010 - 2026)

Analysis

Haemonetics (HAE) EBT Margin Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn -719.00
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 236.00
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 295.00
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 687.00
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 88.00
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 374.00
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn -938.00
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 343.00
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 165.00
10 Haemonetics 4.60 Bn 4.37 Bn 202.80 Mn -4.00
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 -4.00
Mar 28, 2026 -2,960.00
Dec 27, 2025 337.00
Sep 27, 2025 273.00
Jun 28, 2025 16.00
Mar 29, 2025 1,458.00
Dec 28, 2024 123.00
Sep 28, 2024 262.00
Jun 29, 2024 -268.00
Mar 30, 2024 -390.00
Dec 30, 2023 -74.00
Sep 30, 2023 -348.00
Jul 1, 2023 682.00
Apr 1, 2023 493.00
Dec 31, 2022 175.00
Oct 1, 2022 550.00
Jul 2, 2022 1,107.00
Apr 2, 2022 1,796.00
Jan 1, 2022 -347.00
Oct 2, 2021 -1,793.00